Regulators Tighten Rules on Toxin Advertising

Published

Written by...

Share this article

New technology was put in place on January 31 to monitor advertisements on social media relating to the promotion of prescription-only medicines (POMs) such as botulinum toxin.

The Committees of Advertising Practice (CAP) and Medicines and Healthcare products Regulatory Agency (MHRA) issued an Enforcement Notice to the beauty and cosmetic services industry compelling businesses to review ads and make immediate changes. This is the furthest-reaching Enforcement Notice ever issued by CAP, targeting more than 130,000 of the wide-ranging businesses within the cosmetics services industry.
ASA chief executive, Guy Parker said, “We’re taking action to tackle botulinum toxin ads on social media using brand new monitoring technology. This tool helps us to be more efficient and effective in identifying and removing problem ads.” This is the second Enforcement Notice in recent months relating directly to the aesthetic industry. In December 2019, an Enforcement Notice was sent to aesthetic training providers highlighting issues with advertising courses to prospective…

Subscriber content

Continue reading this clinical article

To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.